Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India flag India · Delayed Price · Currency is INR
0.2800
0.00 (0.00%)
At close: Jun 17, 2026

BOM:524661 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
3,655245.5--1.05
Revenue Growth (YoY)
1388.95%----21.26%
Cost of Revenue
3,224205.05---
Gross Profit
431.7140.45--1.05
Selling, General & Admin
1.044.471.030.420.13
Other Operating Expenses
485.398.11-2.25-0.870.68
Operating Expenses
486.6112.65-0.86-0.410.81
Operating Income
-54.927.80.860.410.24
Interest & Investment Income
--0.580.44-
Other Non Operating Income (Expenses)
--0.01--
EBT Excluding Unusual Items
-54.927.81.450.860.24
Gain (Loss) on Sale of Investments
---3.20.16-
Pretax Income
-54.927.8-1.751.020.24
Income Tax Expense
-6.1---
Net Income
-54.921.7-1.751.020.24
Net Income to Common
-54.921.7-1.751.020.24
Net Income Growth
---331.31%-57.24%
Shares Outstanding (Basic)
1,373859149148133
Shares Outstanding (Diluted)
1,373859149148133
Shares Change (YoY)
59.83%477.75%0.54%10.90%-
EPS (Basic)
-0.040.03-0.010.010.00
EPS (Diluted)
-0.040.03-0.010.010.00
EPS Growth
---284.56%-57.25%
Free Cash Flow
17.35-2,220-1.281.070.19
Free Cash Flow Per Share
0.01-2.59-0.010.010.00
Gross Margin
11.81%16.48%--100.00%
Operating Margin
-1.50%11.32%--22.46%
Profit Margin
-1.50%8.84%--22.46%
Free Cash Flow Margin
0.47%-904.46%--17.67%
EBITDA
-54.7127.881.220.44-
EBITDA Margin
-1.50%11.36%---
D&A For EBITDA
0.190.080.360.03-
EBIT
-54.927.80.860.410.24
EBIT Margin
-1.50%11.32%--22.46%
Effective Tax Rate
-21.94%---
Revenue as Reported
3,670264.60.942.371.05
Advertising Expenses
-0.07-0.02-